Inc
Biotechnology• San Diego, CA• Est. 1999
Halozyme Therapeutics Inc
Market Cap
$6.2B
Stock Price
$46.99
HALO
Corporate Profile
Halozyme Therapeutics Inc stands as a titan in the Biotechnology sector. With a valuation of $6.2 Billion, the company employs over 320 people worldwide. Headquartered in San Diego, CA, it continues to drive innovation and maintain its market dominance.
Financial Performance
Revenue
--
Market Cap
$6.2B
Stock
$46.99